Structure and mechanism of metallocarboxypeptidases

Critical Reviews in Biochemistry and Molecular Biology

Volumn 43, Issue 5, 2008, Pages 319-345

  Gomis Ruth, F Xavier ^a  

^a INSTITUT DE BIOLOGIA MOLECULAR DE BARCELONA   (Spain)

Author keywords

Catalysis; Peptide bond hydrolysis; Three dimensional X ray crystal structure; Zinc enzyme

Indexed keywords

CARBOXYPEPTIDASE A; CARBOXYPEPTIDASE B; DIPEPTIDYL CARBOXYPEPTIDASE; ENDOPEPTIDASE 24.16; ENZYME INHIBITOR; GLUTAMIC ACID; METALLOPROTEINASE; MITOCHONDRIAL OLIGOPEPTIDASE; NEUROLYSIN; NEUROTENSIN DEGRADING ENZYME; OLIGOPEPTIDE; PEPTIDASE; PROTEINASE; THIMET OLIGOPEPTIDASE; UNCLASSIFIED DRUG;

BETA SHEET; CARBOXY TERMINAL SEQUENCE; CATALYSIS; ENZYME ACTIVITY; ENZYME BINDING; ENZYME MECHANISM; ENZYME STRUCTURE; ENZYME SUBSTRATE; HUMAN; HYDROLYSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; REVIEW;

ANIMALS; BIOCATALYSIS; CARBOXYPEPTIDASES; CATALYTIC DOMAIN; HUMANS; METALLOPROTEASES; ZINC;

BACTERIA (MICROORGANISMS); BOVINAE; HEXAPODA; MAMMALIA; PROKARYOTA; PROTOZOA;

EID: 54249136672     PISSN: 10409238     EISSN: 15497798     Source Type: Journal    
DOI: 10.1080/10409230802376375     Document Type: Review

References (166)

1. Aagaard, A., Listwan, P., Cowieson, N., Huber, T., Ravasi, T., Wells, C., Flanagan, J.U., Hume, D.A., Kobe, B., and Martin, J.L. 2005. An inflammatory role for the mammalian carboxypeptidase inhibitor latexin: relationship to cystatins and the tumor suppressor TIG1. Structure 13:309-317.
2. Abramowitz, N., Schechter, I., and Berger, A. 1967. On the size of the active site in proteases. II. Carboxypeptidase-A. Biochem Biophys Res Commun 29:862-867.
3. Arndt, J.W., Hao, B., Ramakrishnan, V., Cheng, T., Chan, S.I., and Chan, M.K. 2002. Crystal structure of a novel carboxypeptidase from the hyperthermophilic archaeon Pyrococcus furiosus. Structure 10:215-224.
4. Arolas, J.L., Lorenzo, J., Rovira, A., Castella, J., Aviles, F.X., and Sommerhoff, C.P. 2005a. A carboxypeptidase inhibitor from the tick Rhipicephalus bursa: isolation, cDNA cloning, recombinant expression, and characterization. J Biol Chem 280:3441-3448.
5. Arolas, J.L., Popowicz, G.M., Lorenzo, J., Sommerhoff, C.P., Huber, R., Avilés, F.X., and Holak, T.A. 2005b. The three-dimensional structures of tick carboxypeptidase inhibitor in complex with A/B carboxypeptidases reveal a novel double-headed binding mode. J Mol Biol 350:489-498.
6. Arolas, J.L., Vendrell, J., Avilés, F.X., and Fricker, L.D. 2007. Metallocarboxypeptidases: emerging drug targets in biomedicine. Curr Pharm Des 13:349-366.
7. Auld, D.S. 1987. Acyl group transfer-metalloproteinases, pp. 241-258. In: Page, M.I., and Williams, A., eds, Enzyme Mechanisms, London: Royal Society of Chemistry.
8. Auld, D.S. 1997. Zinc catalysis in metalloproteases. Struct Bond 89:29-50.
9. Auld, D.S. 2004a. 68. Catalytic mechanisms for metallopeptidases, pp. 268-289. In: Barrett, A.J., Rawlings, N.D., and Woessner Jr., J.F., eds, Handbook of Proteolytic Enzymes, Vol. 1. London: Elsevier Academic Press.
10. Auld, D.S. 2004b. 240. Carboxypeptidase A, pp. 812-821. In: Barrett, A.J., Rawlings, N.D., and Woessner Jr., J.F., eds, Handbook of Proteolytic Enzymes, Vol. 1. London: Elsevier Academic Press.
11. Bajzar, L., Manuel, R., and Nesheim, M.E. 1995. Purification and characterization of TAFI, a thrombin-activable fibrinolysis inhibitor. J Biol Chem 270:14477-14484.
12. Barrett, A.J., Rawlings, N.D., and Woessner, J.F. 2004. Handbook of Proteolytic Enzymes. Amsterdam: Elsevier.
13. Baumann, U., Bauer, M., Letoffe, S., Delepelaire, P., and Wandersman, C. 1995. Crystal structure of a complex between Serratia marcescens metallo-protease and an inhibitor from Erwinia chrysanthemi. J Mol Biol 248:653-661.
14. Bayés, A., Fernández, D., Solà, M., Marrero, A., García-Piqué, S., Avilés, F.X., Vendrell, J., and Gomis-Rüth, F.X. 2007. Caught after the Act: A human A-type metallocarboxypeptidase in a product complex with a cleaved hexapeptide. Biochemistry 46:6921-6930.
15. Biechler, S.S. and Taft, R.W.J. 1957. The effect of structure on kinetics and mechanism of the alkaline hydrolysis of anilides. J Am Chem Soc 79:4927-4935.
16. Bode, W., Gomis-Rüth, F.X., and Stöcker, W. 1993. Astacins, serralysins, snake venom and matrix metalloproteinases exhibit identical zinc-binding environments (HEXXHXXGXXH and Met-turn) and topologies and should be grouped into a common family, the 'metzincins'. FEBS Lett 331:134-140.
17. Brändén, C.-I. 1980. Relation between structure and function of α/β proteins. Q Rev Biophys 13:317-338.
18. Brown, C.K., Madauss, K., Lian, W., Beck, M.R., Tolbert, W.D., and Rodgers, D.W. 2001. Structure of neurolysin reveals a deep channel that limits substrate access. Proc Natl Acad Sci USA 98:3127-3132.
19. Bryan, P., Pantoliano, M.W., Quill, S.G., Hsiao, H.Y., and Poulos, T. 1986. Site-directed mutagenesis and the role of the oxyanion hole in subtilisin. Proc Natl Acad Sci USA 83:3743-3745.
20. Bukrinsky, J.T., Bjerrum, M.J., and Kadziola, A. 1998. Native carboxypeptidase A in a new crystal environment reveals a different conformation of the important tyrosine 248. Biochemistry 37:16555-16564.
21. Cappalonga, A.M., Alexander, R.S., and Christianson, D.W. 1992. Structural comparison of sulfodiimine and sulfonamide inhibitors in their complexes with zinc enzymes. J Biol Chem 267:19192-19197.
22. Carranza, C., Inisan, A.-G., Mouthuy-Knoops, E., Cambillau, C., and Roussel, A. 1999. Turbo-Frodo. In: AFMB Activity Report 1996-1999, pp. 89-90. CNRS-UPR 9039, Marseille.
23. Cha, J., and Auld, D.S. 1997. Site-directed mutagenesis of the active site glutamate in human matrilysin: investigation of its role in catalysis. Biochemistry 36:16019-16024.
24. Cheng, T.C., Ramakrishnan, V., and Chan, S.I. 1999. Purification and characterization of a cobalt-activated carboxypeptidase from the hyperthermophilic archaeon Pyrococcus furiosus. Protein Sci 8:2474-2486.
25. Chothia, C. and Lesk, A.M. 1986. The relation between the divergence of sequence and structure in proteins. EMBO J 5:823-826.
26. Christianson, D.W. 1991. Structural biology of zinc. Adv Protein Chem 42:281-355.
27. Christianson, D.W. and Cox, J.D. 1999. Catalysis by metal-activated hydroxide in zinc and manganese metalloenzymes. Annu Rev Biochem 68:33-57.
28. Christianson, D.W. and Lipscomb, W.N. 1989. Carboxypeptidase A. Acc Chem Res 22:62-69.
29. Clore, G.M., Gronenborn, A.M., Nilges, M., and Ryan, C.A. 1987. Three-dimensional structure of potato carboxypeptidase inhibitor in solution. A study using nuclear magnetic resonance, distance geometry, and restrained molecular dynamics. Biochemistry 26:8012-8023.
30. Coleman, D.E., Berghuis, A.M., Lee, E., Linder, M.E., Gilman, A.G., and Sprang, S.R. 1994. Structures of active conformations of Gia1 and the mechanism of GTP hydrolysis. Science 265:1405-1412.
31. Coll, M., Guasch, A., Aviles, F.X., and Huber, R. 1991. Three-dimensional structure of porcine procarboxypeptidase B: a structural basis of its inactivity. EMBO J 10:1-9.
32. Comellas-Bigler, M., Lang, R., Bode, W., and Maskos, K. 2005. Crystal structure of the E. coli dipeptidyl carboxypeptidase Dcp: further indication of a ligand-dependent hinge movement mechanism. J Mol Biol 349:99-112.
33. Cornell, M.J., Williams, T.A., Lamango, N.S., Coates, D., Corvol, P., Soubrier, F., Hoheisel, J., Lehrach, H., and Isaac, R.E. 1995. Cloning and expression of an evolutionary conserved single-domain angiotensin converting enzyme from Drosophila melanogaster. J Biol Chem 270:13613-13619.
34. Corradi, H.R., Schwager, S.L., Nchinda, A.T., Sturrock, E.D., and Acharya, K.R. 2006. Crystal structure of the N domain of human somatic angiotensin I-converting enzyme provides a structural basis for domain-specific inhibitor design. J Mol Biol 357:964-974.
35. Davis, M.I., Bennett, M.J., Thomas, L.M., and Bjorkman, P.J. 2005. Crystal structure of prostate-specific membrane antigen, a tumor marker and peptidase. Proc Natl Acad Sci USA 102:5981-5986.
36. de Wolfe, R.H., and Newcomb, R.C. 1971. Hydrolysis of formanilides in alkaline solutions. J Org Chem 36:3870-3878.
37. Devault, A., Nault, C., Zollinger, M., Fournie-Zaluski, M.C., Roques, B.P., Crine, P., and Boileau, G. 1988. Expression of neutral endopeptidase (enkephalinase) in heterologous COS-1 cells. Characterization of the recombinant enzyme and evidence for a glutamic acid residue at the active site. J Biol Chem 263:4033-4040.
38. Díez-Díaz, M., Conejero, V., Rodrigo, I., Pearce, G., and Ryan, C.A. 2004. Isolation and characterization of wound-inducible carboxypeptidase inhibitor from tomato leaves. Phytochemistry 65:1919-1924.
39. Domingues, F.S., Lackner, P., Andreeva, A., and Sippl, M.J. 2000. Structure-based evaluation of sequence comparison and fold recognition alignment accuracy. J Mol Biol 297:1003-1013.
40. Eaton, D.L., Malloy, B.E., Tsai, S.P., Henzel, W., and Drayna, D. 1991. Isolation, molecular cloning, and partial characterization of a novel carboxypeptidase B from human plasma. J Biol Chem 266:21833-21838.
41. Ehlers, M.R., Fox, E.A., Strydom, D.J., and Riordan, J.F. 1989. Molecular cloning of human testicular angiotensin-converting enzyme: the testis isozyme is identical to the C-terminal half of endothelial angiotensin-converting enzyme. Proc Natl Acad Sci USA 86:7741-7745.
42. Eriksson, S.O., and Holst, C. 1966. Hydrolysis of anilides. II. Hydrolysis of trifluoro- and trichloroacetanilide by hydroxyl ions and by some other catalysts. Acta Chem Scan 20:1892-1906.
43. Esnouf, R.M. 1997. An extensively modified version of Molscript that includes greatly enhanced coloring capabilities. J Mol Graph 15:133-138.
44. Evans, S.V. 1993. SETOR: hardware lighted three-dimensional solid model representations of macromolecules. J Mol Graphics 11:134-138.
45. Faming, Z., Kobe, B., Stewart, C.B., Rutter, W.J., and Goldsmith, E.J. 1991. Structural evolution of an enzyme specificity. The structure of rat carboxypeptidase A2 at 1.9-A resolution. J Biol Chem 266:24606-24612.
46. Fraústo da Silva, J.J.R. and Williams, R.J.P. 2001. The Biological Chemistry of the Elements: the inorganic chemistry of life. New York: Oxford University Press.
47. Fushimi, N., Ee, C.E., Nakajima, T., and Ichishima, E. 1999. Aspzincin, a family of metalloendopeptidases with a new zinc-binding motif. Identification of new zinc-binding sites (His(128), His(132), and Asp(164)) and three catalytically crucial residues (Glu(129), Asp(143), and Tyr(106)) of deuterolysin from Aspergillus oryzae by site-directed mutagenesis. J Biol Chem 274:24195-24201.
48. García-Castellanos, R., Bonet-Figueredo, R., Pallar̀es, I., Ventura, S., Aviles, F.X., Vendrell, J., and Gomis-Rüth, F.X. 2005. Detailed molecular comparison between the inhibition mode of A/B-type carboxypeptidases in the zymogen state and by the endogenous inhibitor latexin. Cell Mol Life Sci 62:1996-2014.
49. García-Sáez, I., Reverter, D., Vendrell, J., Avilés, F.X., and Coll, M. 1997. The three-dimensional structure of human procarboxypeptidase A2. Deciphering the basis of the inhibition, activation and intrinsic activity of the zymogen. EMBO J 16:6906-6913.
50. Gardell, S.J., Craik, C.S., Hilvert, D., Urdea, M.S., and Rutter, W.J. 1985. Site-directed mutagenesis shows that tyrosine 248 of carboxypeptidase A does not play a crucial role in catalysis. Nature 317:551-555.
51. Gerdts, C.J., Tereshko, V., Yadav, M.K., Dementieva, I., Collart, F., Joachimiak, A., Stevens, R.C., Kuhn, P., Kossiakoff, A., and Ismagilov, R.F. 2006. Time-controlled microfluidic seeding in nL-volume droplets to separate nucleation and growth stages of protein crystallization. Angew Chem Int Ed Engl 45:8156-8160.
52. Gerstein, M., and Krebs, W. 1998. A database of macromolecular motions. Nucl Acids Res 26:4280-4290.
53. Gerstein, M., Lesk, A.M., and Chothia, C. 1994. Structural mechanisms for domain movements in proteins. Biochemistry 33:6739-6749.
54. Gomis-Rüth, F.X. 2003. Structural aspects of the metzincin clan of metalloendopeptidases. Mol Biotech 24:157-202.
55. Gomis-Rüth, F.X., Stöcker, W., Huber, R., Zwilling, R., and Bode, W. 1993. Refined 1.8 Å X-ray crystal structure of astacin, a zinc-endopeptidase from the crayfish Astacus astacus L. Structure determination, refinement, molecular structure and comparison with thermolysin. J Mol Biol 229:945-968.
56. Gomis-Rüth, F.X., Kress, L.F., Kellermann, J., Mayr, I., Lee, X., Huber, R., and Bode, W. 1994a. Refined 2.0̊A X-ray crystal structure of the zinc-endopeptidase adamalysin II. Primary and tertiary structure determination, refinement, molecular structure and comparison with astacin, collagenase and thermolysin. J Mol Biol 239:513-544.
57. Gomis-Rüth, F.X., Nar, H., Grams, F., Yallouros, I., Küsthardt, U., Zwilling, R., Bode, W., and Stöcker, W. 1994b. Crystal structures, spectroscopic features and catalytic properties of cobalt(II)-, copper(II)-, nickel(II)-, and mercury(II)-derivatives of the zinc-endopeptidase astacin. A correlation of structure and proteolytic activity. J Biol Chem 269:17111-17117.
58. Gomis-Rüth, F.X., Gómez, M., Bode, W., Huber, R., and Avilés, F.X. 1995. The three-dimensional structure of the native ternary complex of bovine pancreatic procarboxypeptidase A with proproteinase E and chymotrypsinogen C. EMBO J 14:4387-4394.
59. Gomis-Rüth, F.X., Gomez-Ortiz, M., Vendrell, J., Ventura, S., Bode, W., Huber, R., and Aviles, F.X. 1997a. Crystal structure of an oligomer of proteolytic zymogens: detailed conformational analysis of the bovine ternary complex and implications for their activation. J Mol Biol 269:861-880.
60. Gomis-Rüth, F.X., Maskos, K., Betz, M., Bergner, A., Huber, R., Suzuki, K., Yoshida, N., Nagase, H., Brew, K., Bourenkov, G.P., Bartunik, H., and Bode, W. 1997b. Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1. Nature 389:77-81.
61. Gomis-Rüth, F.X., Companys, V., Qian, Y., Fricker, L.D., Vendrell, J., Avilés, F.X., and Coll, M. 1999. Crystal structure of avian carboxypeptidase D domain II: a prototype for the regulatory metallocarboxypeptidase subfamily. EMBO J 18:5817-5826.
62. Gong, H., Zhou, J., Liao, M., Hatta, T., Harnnoi, T., Umemiya, R., Inoue, N., Xuan, X., and Fujisaki, K. 2007. Characterization of a carboxypeptidase inhibitor from the tick Haemaphysalis longicornis. J Insect Physiol 53:1079-1087.
63. Grams, F., Dive, V., Yiotakis, A., Yiallouros, I., Vassiliou, S., Zwilling, R., Bode, W., and Stöcker, W. 1996. Structure of astacin with a transition-state analogue inhibitor. Nature Struc Biol 3:671-675.
64. 2 complex. Inorg Chem 24:2715-2717.
65. Guasch, A., Coll, M., Avilés, F.X., and Huber, R. 1992. Three-dimensional structure of porcine pancreatic procarboxypeptidase A. A comparison of the A and B zymogens and their determinants for inhibition and activation. J Mol Biol 224:141-157.
66. Guindon, S., and Gascuel, O. 2003. A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood. Syst Biol 52:696-704.
67. Guy, J.L., Lambert, D.W., Turner, A.J., and Porter, K.E. 2008. Functional angiotensin converting enzyme-2 (ACE2) is expressed in human cardiac myofibroblasts. Exp Physiol 93:421:551-554.
68. Hangauer, D.G., Monzingo, A.F., and Matthews, B.W. 1984. An interactive computer graphics study of thermolysin-catalyzed peptide cleavage and inhibition by N-carboxymethyl dipeptides. Biochemistry 23:5730-5741.
69. Hartsuck, J.A., and Lipscomb, W.N. 1971. Carboxypeptidase A, pp. 1-56. In: Boyer, P.D., ed. The Enzymes. Hydrolysis: peptide bonds, Vol. III. New York: Academic Press.
70. Hashida, Y., and Inouye, K. 2007. Kinetic analysis of the activation - and-inhibition dual effects of cobalt ion on thermolysin activity. J Biochem 141:843-853.
71. Hendriks, D., Scharpé, S., van Sande, M., and Lommaert, M.P. 1989. Characterisation of a carboxypeptidase in human serum distinct from carboxypeptidase N. J Clin Chem Clin Biochem 27:277-285.
72. Hillmayer, K., Macovei, A., Pauwels, D., Compernolle, G., Declerck, P.J., and Gils, A. 2006. Characterization of rat thrombin-activatable fibrinolysis inhibitor (TAFI) a comparative study assessing the biological equivalence of rat, murine and human TAFI. J Thromb Haemost 4:2470-2477.
73. Hilvert, D., Gardell, S.J., Rutter, W.J., and Kaiser, E.T. 1986. Evidence against a crucial role for the phenolic hydroxyl of Tyr-248 in peptide and ester hydrolyses catalyzed by carboxypeptidase A: Comparative studies of the pH dependencies of the native and Phe-248 mutant forms. J Am Chem Soc 108:5298-5304.
74. Holland, D.R., Tronrud, D.E., Pley, H.W., Flaherty, K.M., Stark, W., Jansonius, J.N., McKay, D.B., and Matthews, B.W. 1992. Structural comparison suggests that thermolysin and related neutral proteases undergo hinge-bending motion during catalysis. Biochemistry 31:11310-11316.
75. Hooper, N.M. 1994. Families of zinc metalloproteases. FEBS Lett 354:1-6.
76. Hooper, N.M. 2002. Proteases: a primer, pp. 1-8. In: Hooper, N.M., ed. Essays in Biochemistry - Proteases in biology and medicine. London: Portland Press.
77. Huang, H., Reed, C.P., Zhang, J.S., Shridhar, V., Wang, L., and Smith, D.I. 1999. Carboxypeptidase A3 (CPA3): a novel gene highly induced by histone deacetylase inhibitors during differentiation of prostate epithelial cancer cells. Cancer Res 59:2981-2988.
78. Hurst, D., Rylett, C.M., Isaac, R.E., and Shirras, A.D. 2003. The Drosophila angiotensin-converting enzyme homologue AnCE is required for spermiogenesis. Dev Biol 254:238-247.
79. Jiang, W. and Bond, J.S. 1992. Families of metalloendopeptidases and their relationships. FEBS Lett 312:110-114.
80. Jongeneel, C.V., Bouvier, J., and Bairoch, A. 1989. A unique signature identifies a family of zinc-dependent metallopeptidases. FEBS Lett 242:211-214.
81. i value in the femtomolar range. Biochemistry 30:8165-8170.
82. Kayashima, T., Yamasaki, K., Yamada, T., Sakai, H., Miwa, N., Ohta, T., Yoshiura, K., Matsumoto, N., Nakane, Y., Kanetake, H., Ishino, F., Niikawa, N., and Kishino, T. 2003. The novel imprinted carboxypeptidase A4 gene (CPA4) in the 7q32 imprinting domain. Hum Genet 112:220-226.
83. Keil, C., Maskos, K., Than, M., Hoopes, J.T., Huber, R., Tan, F., Deddish, P.A., Erdos, E.G., Skidgel, R.A., and Bode, W. 2007. Crystal structure of the human carboxypeptidase N (kininase I) catalytic domain. J Mol Biol 366:504-516.
84. Kester, W.R. and Matthews, B.W. 1977. Crystallographic study of dipeptide inhibitors to thermolysin: implications for the mechanism of catalysis. Biochemistry 16:2506-2516.
85. Kim, H. and Lipscomb, W.N. 1990. Crystal structure of the complex of carboxypeptidase A with a strongly bound phosphonate in a new crystalline form: comparison with structures of other complexes. Biochemistry 29:5546-5555.
86. Kim, H. and Lipscomb, W.N. 1991. Comparison of the structures of three carboxypeptidase A - phosphonate complexes determined by X-ray crystallography. Biochemistry 30:8171-8180.
87. Kim, H.M., Shin, D.R., Yoo, O.J., Lee, H., and Lee, J.O. 2003. Crystal structure of Drosophila angiotensin I-converting enzyme bound to captopril and lisinopril. FEBS Lett 538:65-70.
88. Kuroki, K., Eng, F., Ishikawa, T., Turck, C., Harada, F., and Ganem, D. 1995. gp180, a host cell glycoprotein that binds duck hepatitis B virus particles, is encoded by a member of the carboxypeptidase gene family. J Biol Chem 270:15022-15028.
89. Laethem, R.M., Blumenkopf, T.A., Cory, M., Elwell, L., Moxham, C.P., Ray, P.H., Walton, L.M., and Smith, G.K. 1996. Expression and characterization of human pancreatic preprocarboxypeptidase A1 and preprocarboxypeptidase A2. Archives of Biochemistry & Biophysics 332:8-18.
90. Latt, S.A., Auld, D.S., and Vallee, B.L. 1972. Distance measurements at the active site of carboxypeptidase A during catalysis. Biochemistry 11:3015-3022.
91. Lee, S.H., Minagawa, E., Taguchi, H., Matsuzawa, H., Ohta, T., Kaminogawa, S., and Yamauchi, K. 1992. Purification and characterization of a thermostable carboxypeptidase (carboxypeptidase Taq) from Thermus aquaticus YT-1. Biosci Biotechnol Biochem 56:1839-1844.
92. Lee, S.H., Taguchi, H., Yoshimura, E., Minagawa, E., Kaminogawa, S., Ohta, T., and Matsuzawa, H. 1994. Carboxypeptidase Taq, a thermostable zinc enzyme, from Thermus aquaticus YT-1: molecular cloning, sequencing, and expression of the encoding gene in Escherichia coli. Biosci Biotechnol Biochem 58:1490-1495.
93. Levin, Y., Skidgel, R.A., and Erdos, E.G. 1982. Isolation and characterization of the subunits of human plasma carboxypeptidase N (kininase i). Proc Natl Acad Sci USA 79:4618-4622.
94. Li, F., Li, W., Farzan, M., and Harrison, S.C. 2005. Structure of SARS coronavirus spike receptor-binding domain complexed with receptor. Science 309:1864-1868.
95. Lipscomb, W.N., Hartsuck, J.A., Reeke Jr., G.N., Quiocho, F.A., Bethge, P.H., Ludwig, M.L., Steitz, T.A., Muirhead, H., and Coppola, J.C. 1968. The structure of carboxypeptidase A. VII. The 2.0-Å resolution studies of the enzyme and of its complex with glycyltyrosine, and mechanistic deductions. Brookhaven Symp Biol 21:24-90.
96. López-Otín, C. and Overall, C.M. 2002. Protease degradomics: a new challenge for proteomics. Nat Rev Mol Cell Biol 3:509-519.
97. Lupyan, D., Leo-Macias, A., and Ortiz, A.R. 2005. A new progressive-iterative algorithm for multiple structure alignment. Bioinformatics 21:3255-3263.
98. Mao, S.S., Colussi, D., Bailey, C.M., Bosserman, M., Burlein, C., Gardell, S.J., and Carroll, S.S. 2003. Electrochemiluminescence assay for basic carboxypeptidases: inhibition of basic carboxypeptidases and activation of thrombin-activatable fibrinolysis inhibitor. Anal Biochem 319:159-170.
99. March, J. 1985. Advanced Organic Chemistry - Reactions, mechanisms and structure. New York: John Wiley & Sons.
100. Matthews, B.W. 1988. Structural basis of the action of thermolysin and related zinc peptidases. Acc Chem Res 21:333-340.
101. Matthews, B.W., Jansonius, J.N., Colman, P.M., Schoenborn, B.P., and Dupourque, D. 1972. Three-dimensional structure of thermolysin. Nature 238:37-41.
102. Merz, K.M., Jr. 1990. Insights into the function of the zinc hydroxide-Thr199-Glu106 hydrogen bonding network in carbonic anhydrases. J Mol Biol 214:799-802.
103. Mesters, J.R., Barinka, C., Li, W., Tsukamoto, T., Majer, P., Slusher, B.S., Konvalinka, J., and Hilgenfeld, R. 2006. Structure of glutamate carboxypeptidase II, a drug target in neuronal damage and prostate cancer. EMBO J 25:1375-1384.
104. Mittl, P.R. and Grütter, M.G. 2006. Opportunities for structure-based design of protease-directed drugs. Curr Opin Struct Biol 16:769-775.
105. Monzingo, A.F. and Matthews, B.W. 1984. Binding of N-carboxymethyl dipeptide inhibitors to thermolysin determined by X-ray crystallography: a novel class of transition-state analogues for zinc peptidases. Biochemistry 23:5724-5729.
106. Nagase, H. 2001. Metalloproteases. Curr Protoc Protein Sci Suppl. 24:21.24.21-21.24.13.
107. Nagata, K., Tsutsui, S., Lee, W.C., Ito, K., Kamo, M., Inoue, Y., and Tanokura, M. 2004. Crystallization and preliminary X-ray analysis of carboxypeptidase 1 from Thermus thermophilus. Acta Crystallogr sect D 60:1445-1446.
108. Natesh, R., Schwager, S.L.U., Sturrock, E.D., and Acharya, K.R. 2003. Crystal structure of the human angiotensin-converting enzyme-lysinopril complex. Nature:in press.
109. Neurath, H. 1960. Carboxypeptidases A and B, pp. 11-36. In: Boyer, P.D., Lardy, H.A., and Myrback, K., eds. Enzymes, Vol. 4. New York: Academic Press.
110. Neurath, H. and Walsh, K.A. 1976. Role of proteolytic enzymes in biological regulation. Proc Natl Acad Sci USA 73:3825-3832.
111. Nicholls, A., Bharadwaj, R., and Honig, B. 1993. GRASP: graphical representation and analysis of surface properties. Biophys J 64(2, part 2):A166-A166.
112. Niemirowicz, G. and Cazzulo, J.J. 2007, Changing the substrate specificities of M32 peptidases of T. cruzi by site-directed mutagenesis. XLIII. Annual Congress of the Argentinian Society for Research in Biochemical and Molecular Biology (SAIB), 17-20 November 2007, Mar del Plata (Argentina).
113. Niemirowicz, G., Fernandiz, D., Sola, M., et al. 2008. The molecular analysis of trypanosoma cruzi metallocarboxypeptidase 1 provides insight into fold and substrate specificity. Mol. Microbiol., in press.
114. Niemirowicz, G., Parussini, F., Agüero, F., and Cazzulo, J.J. 2007. Two metallocarboxypeptidases from the protozoan Trypanosoma cruzi belong to the M32 family, found so far only in prokaryotes. Biochem J 401:399-410.
115. Normant, E., Gros, C., and Schwartz, J.C. 1995a. Carboxypeptidase A isoforms produced by distinct genes or alternative splicing in brain and other extrapancreatic tissues. J Biol Chem 270:20543-20549.
116. Normant, E., Martres, M.P., Schwartz, J.C., and Gros, C. 1995b. Purification, cDNA cloning, functional expression, and characterization of a 26-kDa endogenous mammalian carboxypeptidase inhibitor. Proc Natl Acad Sci USA 92:12225-12229.
117. Ollis, D.L., Cheah, E., Cygler, M., Dijkstra, B., Frolow, F., Franken, S.M., Harel, M., Remington, S.J., Silman, I., Schrag, J., Sussman, J.L., Verschueren, K.H.G., and Goldman, A. 1992. The α/β hydrolase fold. Prot Engng 5:197-211.
118. Ortiz, A.R., Strauss, C.E., and Olmea, O. 2002. MAMMOTH (matching molecular models obtained from theory): an automated method for model comparison. Prot Sci 11:2606-2621.
119. Pallar̀es, I., Bonet, R., García-Castellanos, R., Ventura, S., Avilés, F.X., Vendrell, J., and Gomis-Rüth, F.X. 2005. Structure of human carboxypeptidase A4 with its endogenous protein inhibitor, latexin. Proc Natl Acad Sci USA 102:3978-3983.
120. Park, J.D., Kim, D.H., Kim, S.J., Woo, J.R., and Ryu, S.E. 2002. Sulfamide-based inhibitors for carboxypeptidase A. Novel type transition state analogue inhibitors for zinc proteases. J Med Chem 45:5295-5302.
121. Pearson, R.G. 1963. Hard and soft acids and bases. J Am Chem Soc 85:3533-3539.
122. Pereira, P.J.B., Segura-Martín, S., Oliva, B., Ferrer-Orta, C., Avilés, F.X., Coll, M., Gomis-Rüth, F.X., and Vendrell, J. 2002. Human procarboxypeptidase B: three-dimensional structure and implications for thrombin-activatable fibrinolysis inhibitor (TAFI). J Mol Biol 321:537-547.
123. Perriere, G., and Gouy, M. 1996. WWW-query: an on-line retrieval system for biological sequence banks. Biochimie 78:36436-36439.
124. Phillips, M.A., Fletterick, R., and Rutter, W.J. 1990. Arginine 127 stabilizes the transition state in carboxypeptidase. J Biol Chem 265:20692-20698.
125. Polgár, L. 1999. Basic kinetic mechanisms of proteolytic enzymes, pp. 148-166. In: Sterchi, E.E., and Stöcker, W., eds. Proteolytic enzymes - Tools and targets. Berlin/Heidelberg: Springer Verlag.
126. Puente, X.S. and López-Otín, C. 1997. The PLEES-proteins - A family of structurally related enzymes widely distributed from bacteria to humans. Biochem J 332:947-949.
127. Rawlings, N.D., Morton, F.R., Kok, C.Y., Kong, J., and Barrett, A.J. 2008. MEROPS: the peptidase database. Nucleic Acids Res 36 (Database issue):D320-D325.
128. Ray, K., Hines, C.S., Coll-Rodríguez, J., and Rodgers, D.W. 2004. Crystal structure of human thimet oligopeptidase provides insight into substrate recognition, regulation, and localization. J Biol Chem 279:20480-20489.
129. Reeke, G.N., Hartsuck, J.A., Ludwig, M.L., Quiocho, F.A., Steitz, T.A., and Lipscomb, W.N. 1967. The Structure of carboxypeptidase A. VI. Some results at 2.0-Å resolution, and the complex with glycyltyrosine at 2.8-Å resolution. Proc Natl Acad Sci USA 58:2220-2226.
130. Rees, D.C. and Lipscomb, W.N. 1980. Structure of the potato inhibitor complex of carboxypeptidase A at 2.5-A resolution. Proceedings of the National Academy of Sciences of the United States of America 77:4633-4637.
131. Rees, D.C., Lewis, M., and Lipscomb, W.N. 1983. Refined crystal structure of carboxypeptidase A at 1.54 Å resolution. J Mol Biol 168:367-387.
132. Reverter, D., Vendrell, J., Canals, F., Horstmann, J., Avilés, F.X., Fritz, H., and Sommerhoff, C.P. 1998. A carboxypeptidase inhibitor from the medical leech Hirudo medicinalis. Isolation, sequence analysis, cDNA cloning, recombinant expression, and characterization. J Biol Chem 273:32927-32933.
133. Reverter, D., Fernandez-Catalan, C., Baumgartner, R., Pfander, R., Huber, R., Bode, W., Vendrell, J., Holak, T.A., and Aviles, F.X. 2000. Structure of a novel leech carboxypeptidase inhibitor determined free in solution and in complex with human carboxypeptidase A2. Nat Struct Biol 7:322-328.
134. Reverter, D., Maskos, K., Tan, F., Skidgel, R.A., and Bode, W. 2004. Crystal structure of human carboxypeptidase M, a membrane-bound enzyme that regulates peptide hormone activity. J Mol Biol 338:257-269.
135. Reznik, S.E. and Fricker, L.D. 2001. Carboxypeptidases from A to Z: implications in embryonic development and Wnt binding. Cell Mol Life Sci 58:1790-1804.
136. Richardson, J.S. 1981. The anatomy and taxonomy of protein structure. Adv Prot Chem 34:167-339.
137. Richardson, J.S. 1985. Schematic drawings of protein structures. Meth Enzymol 115:359-380.
138. Rost, B. 1999. Twilight zone of protein sequence alignments. Protein Eng 12:85-94.
139. Rowsell, S., Pauptit, R.A., Tucker, A.D., Melton, R.G., Blow, D.M., and Brick, P. 1997. Crystal structure of carboxypeptidase G2, a bacterial enzyme with applications in cancer therapy. Structure 5:337-347.
140. Sanglas, L., Valnickova, Z., Arolas, J.L., Pallarés, I., Guevara, T., Solà, M., Kristensen, T., Enghild, J.J., Avilés, F.X., and Gomis-Rüth, F.X. 2008. Structure of activated thrombin-activatable fibrinolysis inhibitor, a molecular link between coagulation and fibrinolysis. Mol Cell 31:598-606.
141. Saric, T., Beninga, J., Graef, C.I., Akopian, T.N., Rock, K.L., and Goldberg, A.L. 2001. Major histocompatibility complex class I-presented antigenic peptides are degraded in cytosolic extracts primarily by thimet oligopeptidase. J Biol Chem 276:36474-36481.
142. Schmid, M.F. and Herriott, J.R. 1976. Structure of carboxypeptidase B at 2.8 Å resolution. J Mol Biol 103:175-190.
143. Skidgel, R.A. 1988. Basic carboxypeptidases: regulators of peptide hormone activity. Trends Pharmacol Sci 9:299-304.
144. Skidgel, R.A. 1996. Structure and function of mammalian zinc carboxypeptidases, pp. 241-283. In: Hooper, N.M., ed. Zinc Metalloproteases in Health and Disease. London: Taylor and Francis.
145. Skidgel, R.A., Davis, R.M., and Tan, F. 1989. Human carboxypeptidase M. Purification and characterization of a membrane-bound carboxypeptidase that cleaves peptide hormones. J Biol Chem 264:2236-2241.
146. Song, L. and Fricker, L.D. 1997. Cloning and expression of human carboxypeptidase Z, a novel metallocarboxypeptidase. Journal of Biological Chemistry 272:10543-10550.
147. Soubrier, F., Alhenc-Gelas, F., Hubert, C., Allegrini, J., John, M., Tregear, G., and Corvol, P. 1988. Two putative active centers in human angiotensin I-converting enzyme revealed by molecular cloning. Proc Natl Acad Sci USA 85:9386-9390.
148. Springman, E.B. 2004. Mast cell carboxypeptidase, pp. 828-830. In: Barrett, A.J., Rawlings, N.D., and Woessner Jr., J.F., eds, Handbook of Proteolytic Enzymes, Vol. 1. London: Elsevier.
149. Stöcker, W., Grams, F., Baumann, U., Reinemer, P., Gomis-Rüth, F.X., McKay, D.B., and Bode, W. 1995. The metzincins - Topological and sequential relations between the astacins, adamalysins, serralysins, and matrixins (collagenases) define a superfamily of zinc-peptidases. Prot Sci 4:823-840.
150. Stothard, P. 2000. The sequence manipulation suite: JavaScript programs for analyzing and formatting protein and DNA sequences. Biotechniques 28:1102-1104.
151. Sturrock, E.D., Natesh, R., van Rooyen, J.M., and Acharya, K.R. 2004. Structure of angiotensin I-converting enzyme. Cell Mol Life Sci 61:2677-2686.
152. Tan, F., Rehli, M., Krause, S.W., and Skidgel, R.A. 1997. Sequence of human carboxypeptidase D reveals it to be a member of the regulatory carboxypeptidase family with three tandem active site domains. Biochem J 327:81-87.
153. Teplyakov, A., Polyakov, K., Obmolova, G., Strokopytov, B., Kuranova, I., Osterman, A., Grishin, N., Smulevitch, S., Zagnitko, O., Galperina, O., Matz, M., and Stepanov, V. 1992. Crystal structure of carboxypeptidase T from Thermoactinomyces vulgaris. Eur J Biochem 208:281-288.
154. Theobald, D.L. and Wuttke, D.S. 2006. THESEUS: maximum likelihood superpositioning and analysis of macromolecular structures. Bioinformatics 22:2171-2172.
155. Toma, S., Campagnoli, S., De Gregoriis, E., Gianna, R., Margarit, I., Zamai, M., and Grandi, G. 1989. Effect of Glu-143 and His-231 substitutions on the catalytic activity and secretion of Bacillus subtilis neutral protease. Protein Eng 2:359-364.
156. Towler, P., Staker, B., Prasad, S.G., Menon, S., Tang, J., Parsons, T., Ryan, D., Fisher, M., Williams, D., Dales, N.A., Patane, M.A., and Pantoliano, M.W. 2004. ACE2 X-ray structures reveal a large hinge-bending motion important for inhibitor binding and catalysis. J Biol Chem 279:17996-18007.
157. Turner, A.J., Hiscox, J.A., and Hooper, N.M. 2004. ACE2: from vasopeptidase to SARS virus receptor. Trends Pharmacol Sci 25:291-294.
158. Valnickova, Z., Thogersen, I.B., Potempa, J., and Enghild, J.J. 2007. Thrombin-activable fibrinolysis inhibitor (TAFI) zymogen is an active carboxypeptidase. J Biol Chem 282:3066-3076.
159. Vendrell, J., Querol, E., and Avilés, F.X. 2000. Metallocarboxypeptidases and their protein inhibitors. Structure, function and biomedical properties. Biochim Biophys Acta 1477:284-298.
160. Waldschmidt-Leitz, E. and Purr, A. 1929. Über Proteinase und Carboxy-Polypeptidase aus Pankreas. (XVII. Mitteilung zur Spezifizität tierischer Proteasen.). Ber Dt Chem Ges 62:2217-2226.
161. Willemse, J.L. and Hendriks, D.F. 2007. A role for procarboxypepidase U (TAFI) in thrombosis. Front Biosci 12:1973-1987.
162. Willstätter, R., Waldschmidt-Leitz, E., Harden, A., Keilin, D., Haldane, J.B.S., Quastel, J.H., Meldrum, N.U., and Roughton, F.J.W. 1932. Discussion on recent advances in the study of enzymes and their action. Proc Royal Soc London (Series B) 111:280-297.
163. Woodman, Z.L., Schwager, S.L., Redelinghuys, P., Chubb, A.J., van der Merwe, E.L., Ehlers, M.R., and Sturrock, E.D. 2006. Homologous substitution of ACE C-domain regions with N-domain sequences: effect on processing, shedding, and catalytic properties. Biol Chem 387:1043-1051.
164. Xin, X., Varlamov, O., Day, R., Dong, W., Bridgett, M.M., Leiter, E.H., and Fricker, L.D. 1997. Cloning and sequence analysis of cDNA encoding rat carboxypeptidase D. DNA Cell Biol 16:897-905.
165. Yamin, R., Malgeri, E.G., Sloane, J.A., McGraw, W.T., and Abraham, C.R. 1999. Metalloendopeptidase EC 3.4.24.15 is necessary for Alzheimer's amyloid-β peptide degradation. J Biol Chem 274:18777-18784.
166. Zappacosta, F., Pessi, A., Bianchi, E., Venturini, S., Sollazzo, M., Tramontano, A., Marino, G., and Pucci, P. 1996. Probing the tertiary structure of proteins by limited proteolysis and mass spectrometry: the case of Minibody. Prot Sci 5:802-813.